Erasca to Present at the Bank of America Health Care Conference
Erasca to Present at the Bank of America Health Care Conference
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will present on Wednesday, May 15, 2024 at 4:20 pm Pacific Time and will also participate in one-on-one investor meetings.
聖地亞哥，2024年5月7日（GLOBE NEWSWIRE）——Erasca, Inc.（納斯達克股票代碼：ERAS）是一家臨床階段的精準腫瘤公司，專門致力於爲RAS/MAPK路徑驅動的癌症患者發現、開發和商業化療法，今天宣佈參加在內華達州拉斯維加斯安可酒店舉行的美國銀行醫療保健會議。管理層將於太平洋時間2024年5月15日星期三下午 4:20 出席，還將參加一對一的投資者會議。
A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.
該活動的網絡直播將在網上播出 erasca.com/Event。該活動的存檔重播將在網絡直播結束後的30天內公佈 erasca.com/Event。
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipelines in the industry. We believe our team's capabilities and experience, further guided by our scientific advisory board which includes the world's leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
關於埃拉斯卡
在 Erasca，我們的名字就是我們的使命：消滅癌症。我們是一家臨床階段的精準腫瘤學公司，專注於爲RAS/MAPK路徑驅動的癌症患者發現、開發和商業化療法。我們公司由精準腫瘤學和RAS領域的領先先驅共同創立，旨在開發旨在全面關閉癌症治療RAS/MAPK途徑的新療法和聯合方案。我們組裝了業內最深的以RAS/MAPK路徑爲重點的管道之一。我們相信，在包括RAS/MAPK途徑領域的世界領先專家在內的科學顧問委員會的進一步指導下，我們團隊的能力和經驗，使我們能夠獨特地實現消滅癌症的大膽使命。
Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
聯繫人：
喬伊斯·阿萊爾
LifeSci 顧問有限公司
jallaire@lifesciadvisors.com
Source: Erasca, Inc.
資料來源：Erasca, Inc.
Source: Erasca, Inc.
資料來源：Erasca, Inc.
譯文內容由第三人軟體翻譯。